Q.Clear重建能否改善超重神经内分泌肿瘤患者[68Ga]Ga-DOTANOC PET/CT图像质量?
该研究纳入75例BMI≥25的神经内分泌肿瘤(NEN)患者,比较数字PET/CT中Q.Clear不同β水平(800、1000、1600)与标准OSEM重建的图像质量。三位专家盲法视觉评分一致性高(Fleiss κ=0.88),β1600在多数病例中被首选;全人群中β1600与OSEM的CNR、SNR-T和LSNR差异显著(p<0.001),而SUVmean-L无显著差异。结论认为β1600优于β800和β1000,可提高对比噪声比和病灶信噪比。
要点
- β1600在96%肥胖患者和53.3%超重前期患者中被视觉首选。
- β1600与OSEM的CNR、SNR-T、LSNR差异显著(p<0.001),SUVmean-L无显著差异。
- β800和β1000视觉评分始终低于β1600。
核心结论
- 在超重NEN患者的[68Ga]Ga-DOTANOC PET/CT中,Q.Clear的β1600重建优于β800和β1000。
- Q.Clear较标准OSEM可提高CNR和SNR-T,从而优化整体图像质量。
研究设计与样本
- 前瞻性CE批准电子档案中筛选的NEN患者,BMI≥25,于2019年9月至2021年3月行数字PET/CT。
- 共纳入75例患者(中位年龄63岁[23-87]),其中超重前期(25≤BMI<30)50例,肥胖(BMI≥30)25例。
- 图像按EANM指南采集,分别用OSEM和Q.Clear(β=800、1000、1600)重建,由三位不知临床数据的专家独立视觉评分并选择首选β水平。
主要发现
- 75例中PET/CT阳性45例(60.0%),其中肥胖14例、超重前期31例。
- 读者视觉评分一致性高(Fleiss κ=0.88);β1600在96%肥胖患者和53.3%超重前期患者中被首选。
- OSEM在44.7%超重前期和4%肥胖患者中被认为视觉等同于β1600,在2%超重前期患者中被首选。
- 全人群中OSEM与β1600的CNR、SNR-T和LSNR差异显著(p<0.001),SUVmean-L无显著差异;亚组分析结果一致。
- β800和β1000视觉评分始终低于β1600。
关键数值与推荐
- 视觉首选β水平:肥胖组β1600占96%,超重前期组β1600占53.3%。
- OSEM与β1600视觉等同:超重前期组44.7%,肥胖组4%。
- OSEM被首选:超重前期组2%。
- CNR、SNR-T、LSNR在OSEM与β1600间差异显著(p<0.001),SUVmean-L无显著差异。
临床怎么用
- 对BMI≥25的NEN患者行[68Ga]Ga-DOTANOC PET/CT时,可优先考虑Q.Clear β1600重建以改善图像质量。
- 需注意当前PET阳性判读标准可能需针对新重建方法进行调整。
局限性
- 样本量有限,为初步数据。
- 结果需在不同解剖区域和不同大小病灶中进一步验证。
- 目前采用的PET阳性判读标准应针对新重建方法进行调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM/INTRODUCTION: Digital PET/CT allows Q.Clear image reconstruction with different Beta (β) levels. However, no definitive standard β level for [68 Ga]Ga-DOTANOC PET/CT has been established yet. As patient's body mass index (BMI) can affect image quality, the aim of the study was to visually and semi-quantitatively assess different β levels compared to standard OSEM in overweight patients. MATERIALS AND METHODS: Inclusion criteria: (1) patients with NEN included in a prospective CE-approved electronic archive; (2) [68 Ga]Ga-DOTANOC PET/CT performed on a digital tomograph between September2019/March2021; (3) BMI ≥ 25. Images were acquired following EANM guidelines and reconstructed with OSEM and Q.Clear with three β levels (800, 1000, 1600). Scans were independently reviewed by three expert readers, unaware of clinical data, who independently chose the preferred β level reconstruction for visual overall image quality. Semi-quantitative analysis was performed on each scan: SUVmax of the highest uptake lesion (SUVmax-T), liver background SUVmean (SUVmean-L), SUVmax-T/SUVmean-L, Signal-to-noise ratio for both liver (LSNR) and the highest uptake lesion (SNR-T), Contrast-to-noise ratio (CNR). RESULTS: Overall, 75 patients (median age: 63 years old [23-87]) were included: pre-obesity sub-group (25 ≤ BMI < 30, n = 50) and obesity sub-group (BMI ≥ 30, n = 25). PET/CT was positive for disease in 45/75 (60.0%) cases (14 obese and 31 pre-obese patients). Agreement among readers' visual rating was high (Fleiss κ = 0.88) and the β1600 was preferred in most cases (in 96% of obese patients and in 53.3% of pre-obese cases). OSEM was considered visually equal to β1600 in 44.7% of pre-obese cases and in 4% of obese patients. In a minority of pre-obese cases, OSEM was preferred (2%). In the whole population, CNR, SNR-T and LSNR were significantly different (p < 0.001) between OSEM and β1600, conversely to SUVmean-L (not significant). These results were also confirmed when calculated separately for the pre-obesity and obesity sub-groups β800 and β1000 were always rated inferior. CONCLUSIONS: Q.Clear is a new technology for PET/CT image reconstruction that can be used to increase CNR and SNR-T, to subsequently optimise overall image quality as compared to standard OSEM. Our preliminary data on [68 Ga]Ga-DOTANOC PET/CT demonstrate that in overweight NEN patients, β1600 is preferable over β800 and β1000. Further studies are warranted to validate these results in lesions of different anatomical region and size; moreover, currently employed interpretative PET positivity criteria should be adjusted to the new reconstruction method.
引用
- Zanoni L, Argalia G, Fortunati E, et al. Can Q.Clear reconstruction be used to improve [68 Ga]Ga-DOTANOC PET/CT image quality in overweight NEN patients? Eur J Nucl Med Mol Imaging. 2021. PMID: 34693467. doi:10.1007/s00259-021-05592-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。